Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Lisata Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 36 | 34 | −2 |
| Shares | 8.71M | 8.81M | +98.2K (+1.1%) |
| Value | $7.33M | $6.13M | −$1.20M (−16.4%) |
New holders (2)
Institutions that held Lisata Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 18,044 | $13.0K | 0.00% |
| Simplex Trading, LLC | 18,885 | $13.0K | 0.00% |
Sold out (4)
Institutions that held Lisata Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Anson Funds Management LP | 169,432 | $143.0K |
| Virtu Financial LLC | 160,266 | $135.0K |
| Index Fund Advisors, Inc. | 10,434 | $9.00K |
| Spire Wealth Management | 2,278 | $2.00K |